The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin‐1
Open accessAbstract
The potential vasodilator function of the peptide ghrelin, recently identified as the endogenous ligand of the growth hormone secretagogue orphan receptor (GHS‐R), was investigated in human endothelium‐denuded internal mammary artery. The peptide endothelin‐1 (ET‐1) is a potent and long‐lasting vasoconstrictor. Comparisons were made with established and putative endogenous vasodilators to determine if any could reverse ET‐1‐induced vasoconstriction in this vessel. Ghrelin (0.1–300 n M) potently dilated 10 n M ET‐1‐induced constrictions (pD 2 8.39±0.29; E MAX 63±5.6%; n=9/14, responders/total). ANP (pD 2 7.75±0.14; E MAX 106±2.0; n=5/5) and CGRP (pD 2 8.08±0.17; E MAX 76±15% n=5/6) both produced complete reversal of the constrictor response to ET‐1 (E MAX not significantly different from 100%, P>0.05 one‐sample t‐test). The following caused partial reversal of the ET‐1 response: Adrenomedullin (n=9/9) and two peptides derived from proadrenomedullin, PAMP‐12 (n=6/7) and PAMP‐20 (n=9/9) (pD 2 values 7.63±0.28, 7.97±0.23 and 8.51±0.29; E MAX 58±7.3, 54±10 and 51±7.8% respectively). Unexpectedly, amylin was only 2 fold less potent than CGRP, although there was less than 50% reversal of the ET‐1 constriction (pD 2 7.86±0.30; E MAX 41±5.4%; n=7/9). CNP (n=6/6) also partially reversed constrictions to ET‐1 (E MAX 53±6.3; pD 2 8.07±0.38). BNP (n=4/5) and PGI 2 (n=6/8) were weak vasodilators, since concentration‐response curves failed to reach a maximum within the range tested. PGE 2 caused a small dilatation in some vessels (E MAX 17±2.1%; pD 2 8.63±0.36; n=4/8). We have demonstrated ghrelin to be an effective, endothelium‐independent vasodilator of the long‐lasting constrictor ET‐1 in human arteries producing responses similar to those of adrenomedullin (P>0.05, ANOVA). British Journal of Pharmacology (2002) 136, 1146–1152. doi:10.1038/sj.bjp.0704815
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human Pheochromocytoma
Kitamura, K., Kangawa, K., Kawamoto, M., Ichiki, Y., Nakamura, S., Matsuo, H., & Eto, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1451 · Cited by 2,192
Cited by
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
van der Lely, A. J., Tschöp, M., Heiman, M. L., & Ghigo, E. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0029 · Cited by 1,187
Ghrelin?a hormone with multiple functions
KORBONITS, M. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.03.002 · Cited by 595
Nagaya, N., Moriya, J., Yasumura, Y., Uematsu, M., Ono, F., Shimizu, W., Ueno, K., Kitakaze, M., Miyatake, K., & Kangawa, K. (2004) · Circulation · doi:10.1161/01.cir.0000149746.62908.bb · Cited by 523
Maguire, J. J., Kleinz, M. J., Pitkin, S. L., & Davenport, A. P. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.134619 · Cited by 323
Self-citationHemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation
Allen, B. W., Stamler, J. S., & Piantadosi, C. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.08.002 · Cited by 165
Metadata
- Authors
- Wiley, K. E., & Davenport, A. P.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2002-08
- Volume
- 136
- Issue
- 8
- Pages
- 1146-1152
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2102790142
- Cited by
- 212
- References
- 2
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin‐1. https://app.cochat.ai/papers/10.1038/sj.bjp.0704815
- The paper
- Wiley, K. E., & Davenport, A. P. (2002). Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin‐1. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0704815
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.